CurKOA trial - A randomised trial of Curcuma Longa for treating symptoms and effusion-synovitis of knee osteoarthritis
CurKOA trial - A randomised trial of Curcuma Longa for treating symptoms and effusion-synovitis of knee osteoarthritis.
You are invited to participate in this research study. The trial is investigating an experimental treatment for pain and swelling caused by osteoarthritis of the knee. The study is being conducted by Dr Benny Eathakkattu Antony at the Menzies Institute for Medical Research, University of Tasmania in Hobart.
Before you decide whether or not you wish to participate in this study, it is important for you to understand why the research is being done and what it will involve. Please take the time to read the information sheet and consent form in the link below.
What is the purpose of this study?
This study will examine a new treatment for knee pain and swelling. The treatment is the natural extract of Curcuma Longa (turmeric). This study will determine whether treating people with Curcuma Longa extract, when compared with an inactive placebo, will improve knee pain, reduce swelling and slow down the progression of knee osteoarthritis.
Who is invited to participate?
A total of 70 people will participate in this study. People can be considered for inclusion into the study if they:
- Are at least 40 years old
- Have had significant knee pain on most days for more than 6 months AND
- Have swelling in the painful knee
- Are able to complete clinical assessments (including MRI) and questionnaires
- Have an email address and access to the internet
….. if this sounds like you, please read the information sheet and consent form in the link below
For further information regarding the CurKOA trial:
Clinical Trial Coordinator, CurKOA Trial
Menzies Institute for Medical Research
Ph: 6226 4369 (Wed/Thur) or email Gudrun.Wells@utas.edu.au
This study is funded by the Menzies Institute for Medical Research and Natural Remedies Ltd, and has been approved by the Human Research Ethics Committee (Tasmania) Network (Ethics # H00116713).